• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估复发性溃疡性结肠炎患者的肛肠功能。

Assessing anorectal function in patients with recurrent ulcerative colitis.

机构信息

Department of Gastroenterology, The First Affiliated Hospital of Ningbo University, No. 59, Liuting Street, Zhejiang Province, Ningbo, 315010, China.

Ningbo Key Laboratory of Translational Medicine Research On Gastroenterology and Hepatology, No. 59, Liuting Street, Zhejiang Province, Ningbo, 315010, China.

出版信息

Int J Colorectal Dis. 2024 Jul 16;39(1):110. doi: 10.1007/s00384-024-04680-1.

DOI:10.1007/s00384-024-04680-1
PMID:39009899
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11249410/
Abstract

PURPOSE

Ulcerative colitis (UC) is an inflammatory bowel disease with an unclear etiology that can lead to irreversible changes in distal colonic function in chronic patients. This study investigated anorectal function in recurrent UC patients and identified influencing factors.

METHODS

This prospective study enrolled 33 recurrent UC patients and 40 newly diagnosed patients from January 2019 to December 2022. Data collection included clinical records, scores, and anorectal function assessments. Regression analyses were used to identify factors impacting anorectal function.

RESULTS

Recurrent UC patients had higher baseline CRP and fecal calprotectin levels, increased anxiety and depression, and more severe fecal incontinence. They also had lower BMIs, serum Hb and albumin (ALB) levels, and Inflammatory Bowel Disease Questionnaire scores than did initial-onset UC patients. Multivariate linear regression analysis revealed that long disease duration (coef. - 0.376, P < 0.001) and high fecal calprotectin level (coef. - 0.656, P < 0.001) independently influenced the initial sensation threshold in recurrent UC patients. Additionally, high fecal calprotectin (coef. - 0.073, P = 0.013) and high Zung Self-Rating Anxiety Scale score (coef. - 0.489, P = 0.001) were identified as two independent determinants of the defecation volume threshold. For the defecation urgency threshold, the independent factors included high disease duration (coef. - 0.358, P = 0.017) and high fecal calprotectin level (coef. - 0.499, P = 0.001). Similarly, the sole independent factor identified for the maximum capacity threshold was high fecal calprotectin (coef. - 0.691, P = 0.001).

CONCLUSION

Recurrent UC patients had increased rectal sensitivity and compromised anorectal function, which significantly impacted quality of life. Proactively managing the disease, reducing UC relapses, and addressing anxiety are effective measures for improving anorectal function in these patients.

摘要

目的

溃疡性结肠炎(UC)是一种病因不明的炎症性肠病,可导致慢性患者远端结肠功能发生不可逆转的变化。本研究旨在调查复发性 UC 患者的肛肠功能,并确定影响肛肠功能的因素。

方法

本前瞻性研究纳入了 2019 年 1 月至 2022 年 12 月期间的 33 例复发性 UC 患者和 40 例初发性 UC 患者。数据收集包括临床记录、评分和肛肠功能评估。采用回归分析来确定影响肛肠功能的因素。

结果

复发性 UC 患者的基线 CRP 和粪便钙卫蛋白水平较高,焦虑和抑郁评分较高,粪便失禁较严重。与初发性 UC 患者相比,他们的 BMI、血清 Hb 和白蛋白(ALB)水平以及炎症性肠病问卷评分较低。多变量线性回归分析显示,疾病病程长(系数-0.376,P<0.001)和粪便钙卫蛋白水平高(系数-0.656,P<0.001)是复发性 UC 患者初始感觉阈值的独立影响因素。此外,粪便钙卫蛋白高(系数-0.073,P=0.013)和 Zung 自评焦虑量表评分高(系数-0.489,P=0.001)是排便量阈值的两个独立决定因素。对于排便急迫阈值,独立因素包括疾病病程长(系数-0.358,P=0.017)和粪便钙卫蛋白水平高(系数-0.499,P=0.001)。同样,最大容量阈值的唯一独立因素是粪便钙卫蛋白高(系数-0.691,P=0.001)。

结论

复发性 UC 患者直肠敏感性增加,肛肠功能受损,严重影响生活质量。积极治疗疾病、减少 UC 复发以及缓解焦虑是改善此类患者肛肠功能的有效措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6d0/11249410/5b01820ca17d/384_2024_4680_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6d0/11249410/4505467db4f2/384_2024_4680_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6d0/11249410/5b01820ca17d/384_2024_4680_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6d0/11249410/4505467db4f2/384_2024_4680_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6d0/11249410/5b01820ca17d/384_2024_4680_Fig2_HTML.jpg

相似文献

1
Assessing anorectal function in patients with recurrent ulcerative colitis.评估复发性溃疡性结肠炎患者的肛肠功能。
Int J Colorectal Dis. 2024 Jul 16;39(1):110. doi: 10.1007/s00384-024-04680-1.
2
Anorectal manometry in active and quiescent ulcerative colitis.活动期和静止期溃疡性结肠炎的肛门直肠测压
Am J Gastroenterol. 1989 Aug;84(8):892-7.
3
Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse.粪便钙卫蛋白和乳铁蛋白用于预测炎症性肠病复发
Inflamm Bowel Dis. 2009 Aug;15(8):1190-8. doi: 10.1002/ibd.20933.
4
Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?粪便钙卫蛋白能否预测克罗恩病和溃疡性结肠炎患者的复发?
J Crohns Colitis. 2010 Jun;4(2):144-52. doi: 10.1016/j.crohns.2009.09.008. Epub 2009 Dec 2.
5
Fecal calprotectin and lactoferrin as predictors of relapse in patients with quiescent ulcerative colitis during maintenance therapy.粪便钙卫蛋白和乳铁蛋白作为静止期溃疡性结肠炎患者维持治疗期间复发的预测指标。
Int J Colorectal Dis. 2014 Apr;29(4):485-91. doi: 10.1007/s00384-013-1817-3. Epub 2013 Dec 17.
6
Bi-directionality of Brain-Gut Interactions in Patients With Inflammatory Bowel Disease.炎症性肠病患者的脑-肠相互作用的双向性。
Gastroenterology. 2018 May;154(6):1635-1646.e3. doi: 10.1053/j.gastro.2018.01.027. Epub 2018 Jan 31.
7
Fecal calprotectin mirrors inflammation of the distal ileum and bowel function after restorative proctocolectomy for pediatric-onset ulcerative colitis.粪便钙卫蛋白可反映儿童发病溃疡性结肠炎行直肠结肠切除术后回肠末端和肠道功能的炎症情况。
Inflamm Bowel Dis. 2010 Mar;16(3):482-6. doi: 10.1002/ibd.21069.
8
Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.溃疡性结肠炎日本患者实用粪便钙卫蛋白截断值。
World J Gastroenterol. 2018 Oct 14;24(38):4384-4392. doi: 10.3748/wjg.v24.i38.4384.
9
Anorectal Function After Ileo-Rectal Anastomosis Is Better than Pelvic Pouch in Selected Ulcerative Colitis Patients.溃疡性结肠炎患者中,回肠直肠吻合术的肛门直肠功能优于盆腔袋。
Dig Dis Sci. 2020 Jan;65(1):250-259. doi: 10.1007/s10620-019-05757-6. Epub 2019 Aug 1.
10
Eicosapentaenoic Acid Reduces Fecal Levels of Calprotectin and Prevents Relapse in Patients With Ulcerative Colitis.二十碳五烯酸可降低溃疡性结肠炎患者粪便钙卫蛋白水平并预防复发。
Clin Gastroenterol Hepatol. 2018 Aug;16(8):1268-1275.e2. doi: 10.1016/j.cgh.2018.01.036. Epub 2018 Jan 31.

本文引用的文献

1
Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies.埃特拉莫德用于溃疡性结肠炎的诱导和维持治疗(ELEVATE):两项随机、双盲、安慰剂对照的3期研究。
Lancet. 2023 Apr 8;401(10383):1159-1171. doi: 10.1016/S0140-6736(23)00061-2. Epub 2023 Mar 2.
2
Temporal changes in functional outcomes of stapled and hand-sewn ileal pouch-anal anastomosis for ulcerative colitis and familial adenomatous polyposis.吻合口部位在溃疡性结肠炎和家族性腺瘤性息肉病经肛门直肠吻合术中的功能结局的时间变化:吻合钉技术与手工缝合技术的比较。
Colorectal Dis. 2023 Mar;25(3):396-403. doi: 10.1111/codi.16397. Epub 2022 Nov 14.
3
Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis.
生物制剂和小分子药物治疗中重度溃疡性结肠炎患者的疗效和安全性:系统评价和网络荟萃分析。
Lancet Gastroenterol Hepatol. 2022 Feb;7(2):161-170. doi: 10.1016/S2468-1253(21)00377-0. Epub 2021 Nov 29.
4
Real-World Efficacy and Safety Monitoring for Predicting Continuation of Tofacitinib Therapy in Patients with Ulcerative Colitis.真实世界疗效和安全性监测预测溃疡性结肠炎患者托法替布治疗的持续。
Dig Dis Sci. 2022 Aug;67(8):3984-3992. doi: 10.1007/s10620-021-07233-6. Epub 2021 Aug 30.
5
The impact of body mass index on efficacy and safety in the tofacitinib OCTAVE ulcerative colitis clinical programme.体质量指数对托法替布 OCTAVE 溃疡性结肠炎临床研究项目疗效和安全性的影响。
Aliment Pharmacol Ther. 2021 Aug;54(4):429-440. doi: 10.1111/apt.16439. Epub 2021 Jun 24.
6
Upadacitinib Treatment Improves Symptoms of Bowel Urgency and Abdominal Pain, and Correlates With Quality of Life Improvements in Patients With Moderate to Severe Ulcerative Colitis.乌帕替尼治疗可改善中度至重度溃疡性结肠炎患者的急迫性排便和腹痛症状,并与生活质量改善相关。
J Crohns Colitis. 2021 Dec 18;15(12):2022-2030. doi: 10.1093/ecco-jcc/jjab099.
7
New Therapeutics for Ulcerative Colitis.溃疡性结肠炎的新疗法。
Annu Rev Med. 2021 Jan 27;72:199-213. doi: 10.1146/annurev-med-052919-120048.
8
Efficacy and Safety of (Kushen) Based Traditional Chinese Medicine in the Treatment of Ulcerative Colitis: Clinical Evidence and Potential Mechanisms.基于苦参的中药治疗溃疡性结肠炎的疗效与安全性:临床证据及潜在机制
Front Pharmacol. 2020 Dec 10;11:603476. doi: 10.3389/fphar.2020.603476. eCollection 2020.
9
Ulcerative colitis.溃疡性结肠炎。
Nat Rev Dis Primers. 2020 Sep 10;6(1):74. doi: 10.1038/s41572-020-0205-x.
10
Role of Ulcerative Colitis Endoscopic Index of Severity (UCEIS) versus Mayo Endoscopic Subscore (MES) in Predicting Patients' Response to Biological Therapy and the Need for Colectomy.溃疡性结肠炎内镜严重指数(UCEIS)与 Mayo 内镜亚评分(MES)在预测生物治疗患者反应和结肠切除需求中的作用。
Digestion. 2021;102(4):534-545. doi: 10.1159/000509512. Epub 2020 Jul 31.